SEC Form 4 · accession 0001171843-17-005763
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard G Morrison
Director
Period of report
Sep 26, 2017
Accepted (ET)
Sep 28, 2017 · 11:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.17 | Sep 26, 2017 | A | 30,000 | A | — | Sep 26, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option was granted on September 26, 2017 and vest in equal amounts quarterly over the next three years.